These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11958980)

  • 1. Antibody-catalyzed cleavage of the D-Ala-D-Lac depsipeptide: an immunological approach to the problem of vancomycin resistance.
    Isomura S; Ashley JA; Wirsching P; Janda KD
    Bioorg Med Chem Lett; 2002 Mar; 12(6):861-4. PubMed ID: 11958980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine catalytic antibodies: the primary importance of linker effects.
    Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD
    Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of flexible and constrained haptens in eliciting antibody catalysts for paraoxon hydrolysis.
    Spivak DA; Hoffman TZ; Moore AH; Taylor MJ; Janda KD
    Bioorg Med Chem; 1999 Jun; 7(6):1145-50. PubMed ID: 10428386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.
    Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS
    Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of chiral and racemic phosphonate-based haptens for the induction of aldolase catalytic antibodies.
    Mu YQ; Gibbs RA
    Bioorg Med Chem; 1997 Jul; 5(7):1327-37. PubMed ID: 9377093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive immunization.
    Wirsching P; Ashley JA; Lo CH; Janda KD; Lerner RA
    Science; 1995 Dec; 270(5243):1775-82. PubMed ID: 8525366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective cleavage of D-Ala-D-Lac by small molecules: re-sensitizing resistant bacteria to vancomycin.
    Chiosis G; Boneca IG
    Science; 2001 Aug; 293(5534):1484-7. PubMed ID: 11520986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total synthesis and evaluation of [Psi[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Crowley BM; Boger DL
    J Am Chem Soc; 2006 Mar; 128(9):2885-92. PubMed ID: 16506767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity.
    Tawfik DS; Zemel RR; Arad-Yellin R; Green BS; Eshhar Z
    Biochemistry; 1990 Oct; 29(42):9916-21. PubMed ID: 2271630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved rapid method for selecting monoclonal antibodies with high catalytic activities.
    Yuan YR; Yang BH; Ji YY
    J Protein Chem; 1997 Nov; 16(8):733-8. PubMed ID: 9365921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient antibody-catalyzed aminoacylation reaction.
    Jacobsen JR; Prudent JR; Kochersperger L; Yonkovich S; Schultz PG
    Science; 1992 Apr; 256(5055):365-7. PubMed ID: 1566082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain of D-alanyl-D-lactate or D-lactyl-D-alanine synthetase activities in three active-site mutants of the Escherichia coli D-alanyl-D-alanine ligase B.
    Park IS; Lin CH; Walsh CT
    Biochemistry; 1996 Aug; 35(32):10464-71. PubMed ID: 8756703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants for differential effects on D-Ala-D-lactate vs D-Ala-D-Ala formation by the VanA ligase from vancomycin-resistant enterococci.
    Lessard IA; Healy VL; Park IS; Walsh CT
    Biochemistry; 1999 Oct; 38(42):14006-22. PubMed ID: 10529248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide synthesis catalyzed by an antibody containing a binding site for variable amino acids.
    Hirschmann R; Smith AB; Taylor CM; Benkovic PA; Taylor SD; Yager KM; Sprengeler PA; Benkovic SJ
    Science; 1994 Jul; 265(5169):234-7. PubMed ID: 8023141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
    Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD
    Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A catalytic antibody against a tocopherol cyclase inhibitor.
    Manetsch R; Zheng L; Reymond MT; Woggon WD; Reymond JL
    Chemistry; 2004 May; 10(10):2487-506. PubMed ID: 15146522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Mannosidase activity from antibody raised against a glucal antigen.
    Yu J
    Bioorg Med Chem Lett; 1998 May; 8(10):1145-8. PubMed ID: 9871724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New strategies for the design of catalytic antibodies.
    Janda KD
    Biotechnol Prog; 1990; 6(3):178-81. PubMed ID: 1366610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-catalyzed reversal of chemoselectivity.
    Sinha SC; Keinan E; Reymond JL
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11910-3. PubMed ID: 8265647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions.
    McComas CC; Crowley BM; Boger DL
    J Am Chem Soc; 2003 Aug; 125(31):9314-5. PubMed ID: 12889959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.